Health and Fitness Health and Fitness
Fri, September 2, 2011
[ 01:15 AM ] - Market Wire
Senetek Announces Exercise of Put Option With Respect to Relief Canyon Project
[ 01:05 AM ] - Market Wire
Hawaii, Arkansas and Oklahoma Lead the Nation for .. Workforce, Reveals Quest Diagnostics Drug Testing
Thu, September 1, 2011
[ 04:00 PM ] - Market Wire
Brookdale Senior Living Completes Acquisition of .. and Right of First Offer on Chartwell Communities
[ 01:00 PM ] - Market Wire
Advitech Retains Investor Relations Firm
[ 12:00 PM ] - Market Wire
Nuvo Research to Present at Upcoming Healthcare Conferences
[ 04:30 AM ] - Market Wire
Burcon files NASDAQ listing application
[ 12:59 AM ] - Market Wire
STRYKER firma un acuerdo definitivo para adquirir CONCENTRIC MEDICAL, Inc.
[ 12:40 AM ] - Market Wire
Delcath Announces Top-Line Results From Metastati .. ohort in Phase II Trial of Chemosaturation System
[ 12:40 AM ] - Market Wire
Help Your Favorite Charity Win $1,000 from Cold-EEZE®!
Wed, August 31, 2011
[ 04:00 PM ] - Market Wire
Cadence Pharmaceuticals to Present at Three Inves .. nt Conferences During the Month of September 2011
[ 04:00 PM ] - Market Wire
Avanir Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference
[ 04:00 PM ] - Market Wire
BioSante Pharmaceuticals, Inc. Selected For "100 Great Investigational Drugs"
[ 04:00 PM ] - Market Wire
Concord Medical Services Announces the Appointmen .. of Mr. Adam Sun as Acting Chief Financial Officer
[ 04:00 PM ] - Market Wire
STRYKER unterzeichnet endgltiges bereinkommen zur bernahme von CONCENTRIC MEDICAL, Inc.
[ 04:00 PM ] - Market Wire
Vanda Pharmaceuticals to Participate in Stifel Ni .. erence and Jefferies Fall 2011 Mid-Atlantic Corpo
[ 03:00 PM ] - Market Wire
Auxilium Pharmaceuticals, Inc. and BioSpecifics T .. ans to Develop Additional Indications using XIAFL
[ 01:30 PM ] - Market Wire
Gilead Sciences to Present at Bairda?s 2011 Health Care Conference on Thursday, September 8
[ 01:05 PM ] - Market Wire
Health Management Associates, Inc. to Present at .. bert W. Baird & Co.'s 2011 Health Care Conference
[ 01:00 PM ] - Market Wire
Anacor Pharmaceuticals and Medicines for Malaria .. Agreement for AN3661 for the Treatment of Malaria
[ 01:00 PM ] - Market Wire
Alkermesa? Corporate Presentation to Be Webcast at Bairda?s 2011 Health Care Conference
[ 12:32 PM ] - Market Wire
Daniel Thorne announces acquisition of shares of Hamilton Thorne Ltd.
[ 09:35 AM ] - Market Wire
Medtronic Completes Acquisitions of PEAK Surgical, Inc. and Salient Surgical Technologies, Inc.
[ 08:03 AM ] - Market Wire
Dr. Reddya?s Announces Settlement of Lipitor® (atorvastatin) ANDA Litigation with Pfizer
[ 08:00 AM ] - Market Wire
Community Health Systems to Participate in Robert W. Baird & Co.a?s 2011 Health Care Conference
[ 08:00 AM ] - Market Wire
Medtronic Starts New U.S. Study of Endurant® AAA Stent Graft
[ 07:05 AM ] - Market Wire
Magellana?s Medical Pharmacy Solutions Receives URAC Health Utilization Management Accreditation
[ 07:00 AM ] - Market Wire
Alexion to Present at the Stifel Nicolaus Healthcare Conference 2011
[ 06:07 AM ] - Market Wire
Cipher receives Health Canada approval for extended-release tramadol
[ 05:00 AM ] - Market Wire
Five Star Quality Care, Inc. to Present at the St .. colaus Healthcare Conference on September 7, 2011
[ 04:00 AM ] - Market Wire
GTx Announces Panel Discussion at Citia?s 6th Annual Biotech Day

GTx Announces Panel Discussion at Citia?s 6th Annual Biotech Day


Published on 2011-08-31 04:07:00 - Market Wire
  Print publication without navigation


MEMPHIS, Tenn.--([ BUSINESS WIRE ])--GTx, Inc. (NASDAQ: GTXI) announced today that Dr. Mitchell S. Steiner, CEO, is scheduled to participate in a panel discussion on the topic aFinally, Lots of Options for Treating Prostate Cancer a at Citia™s 6th Annual Biotech Day on Wednesday, September 7, 2011, at 11:00 a.m. ET. The conference will be held at the Ritz Carlton hotel in Boston, Massachusetts.

"Finally, Lots of Options for Treating Prostate Cancer"

About GTx

GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules that selectively target hormone pathways for the treatment of cancer, cancer supportive care, and other serious medical conditions.

Contributing Sources